Loading…
Loading…
CANSF does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for CANSF and 80,000+ other tickers.
See exactly how CANSF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CANSF and 80,000+ other tickers.
Atlas Energy Corp. is a biotechnology firm established in 2019 and headquartered in Calgary, Canada. The company specializes in the creation, manufacturing, and distribution of plant-based ingredients, primarily catering to the consumer care, food and beverage, and pharmaceutical industries throughout the United States. Atlas Energy Corp. maintains a strategic licensing and development partnership with Laurus Labs, focusing on the advancement and commercialization of active pharmaceutical ingredients and various other compounds. The company, previously known as Willow Biosciences Inc., officially adopted the name Atlas Energy Corp. in June 2025.
CALGARY, Alberta, June 22, 2026 (GLOBE NEWSWIRE) -- Atlas Energy Corp. (“Atlas” or the “Company”) (TSXV: ATLE), a TSXV Sandbox issuer, is pleased to announce that Patrick Drouin and Dion Degrand will be appointed to the board of directors of Atlas Energy International SEZC, the Company's Cayman Islands subsidiary, subject to receipt of applicable Cayman Islands regulatory approvals.
CALGARY, Alberta, May 13, 2026 (GLOBE NEWSWIRE) -- Atlas Energy Corp. (“Atlas” or the “Company”) (TSXV: ATLE), a TSXV Sandbox issuer, is pleased to announce its financial and operating results for the three months ended March 31, 2026. Selected financial and operational information is outlined below and should be read with Atlas' consolidated financial statements and management's discussion and analysis (“MD&A”) as of March 31, 2026, which are available on the Company's SEDAR+ profile at www.sedarplus.ca.
CALGARY, Alberta, April 06, 2026 (GLOBE NEWSWIRE) -- Atlas Energy Corp. (“Atlas” or the “Company”) (TSXV: ATLE), a TSXV Sandbox issuer, is pleased to announce its financial and operating results for the three months and year ended December 31, 2025, and filing of its Annual Information Form (“AIF”). Selected financial and operational information is outlined below and should be read with Atlas' audited consolidated financial statements and management's discussion and analysis (“MD&A”) as of December 31, 2025, which are available on the Company's SEDAR+ profile at www.sedarplus.ca.
CALGARY, AB , May 12, 2025 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), announces its unaudited consolidated interim financial statements and related management's discussion and analysis ("MD&A") for the quarter ended March 31, 2025, are available on the Company's SEDAR+ profile at www.sedarplus.ca. About Willow Biosciences Willow Biosciences Inc. is a corporation existing under the laws of the Province of Alberta.
CALGARY, AB , April 30, 2025 /PRNewswire/ - Willow Biosciences Inc. (the "Company") (TSX: WLLW) (OTCQB: CANSF) announces the completion today of the sale (the "Transaction") of its wholly-owned operating subsidiary, Epimeron USA, Inc., to the U.S. subsidiary of Mycofeast Ltd., a privately-held, arms-length entity based in the United Kingdom (the "Purchaser"), pursuant to the terms of a share purchase agreement dated March 14, 2025 (the "Share Purchase Agreement"), between the Company and the Purchaser.